243 related articles for article (PubMed ID: 2473082)
21. Vascular endothelial growth factor is inactivated by binding to alpha 2-macroglobulin and the binding is inhibited by heparin.
Soker S; Svahn CM; Neufeld G
J Biol Chem; 1993 Apr; 268(11):7685-91. PubMed ID: 7681826
[TBL] [Abstract][Full Text] [Related]
22. Analysis of the mitogenic effect of fetuin preparations on arterial smooth muscle cells: the role of contaminant platelet-derived growth factor.
Libby P; Raines EW; Cullinane PM; Ross R
J Cell Physiol; 1985 Dec; 125(3):357-66. PubMed ID: 2415538
[TBL] [Abstract][Full Text] [Related]
23. Vascular smooth muscle cells express distinct transforming growth factor-beta receptor phenotypes as a function of cell density in culture.
Goodman LV; Majack RA
J Biol Chem; 1989 Mar; 264(9):5241-4. PubMed ID: 2538477
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of serum and transforming growth factor beta (TGF-beta1)-induced DNA synthesis in confluent airway smooth muscle by heparin.
Okona-Mensah KB; Shittu E; Page C; Costello J; Kilfeather SA
Br J Pharmacol; 1998 Oct; 125(4):599-606. PubMed ID: 9831891
[TBL] [Abstract][Full Text] [Related]
25. Identification of the high affinity binding site in transforming growth factor-beta involved in complex formation with alpha 2-macroglobulin. Implications regarding the molecular mechanisms of complex formation between alpha 2-macroglobulin and growth factors, cytokines, and hormones.
Liu Q; Ling TY; Shieh HS; Johnson FE; Huang JS; Huang SS
J Biol Chem; 2001 Dec; 276(49):46212-8. PubMed ID: 11583997
[TBL] [Abstract][Full Text] [Related]
26. Evidence for an age-related dysfunction in the antiproliferative response to transforming growth factor-beta in vascular smooth muscle cells.
McCaffrey TA; Falcone DJ
Mol Biol Cell; 1993 Mar; 4(3):315-22. PubMed ID: 8387357
[TBL] [Abstract][Full Text] [Related]
27. Differences in the binding of transforming growth factor beta 1 to the acute-phase reactant and constitutively synthesized alpha-macroglobulins of rat.
Webb DJ; Crookston KP; Figler NL; Lamarre J; Gonias SL
Biochem J; 1995 Dec; 312 ( Pt 2)(Pt 2):579-86. PubMed ID: 8526873
[TBL] [Abstract][Full Text] [Related]
28. Rat vascular smooth muscle cells immortalized with SV40 large T antigen possess defined smooth muscle cell characteristics including growth inhibition by heparin.
Reilly CF
J Cell Physiol; 1990 Feb; 142(2):342-51. PubMed ID: 2154504
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of transforming growth factor-beta-induced cataractous changes in lens explants by ocular media and alpha 2-macroglobulin.
Schulz MW; Chamberlain CG; McAvoy JW
Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1509-19. PubMed ID: 8675393
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of mink lung epithelial cell proliferation by transforming growth factor-beta is coupled through a pertussis-toxin-sensitive substrate.
Howe PH; Cunningham MR; Leof EB
Biochem J; 1990 Mar; 266(2):537-43. PubMed ID: 2156499
[TBL] [Abstract][Full Text] [Related]
31. Heparin decreases the rate of proliferation of rat vascular smooth muscle cells by releasing transforming growth factor beta-like activity from serum.
Grainger DJ; Witchell CM; Watson JV; Metcalfe JC; Weissberg PL
Cardiovasc Res; 1993 Dec; 27(12):2238-47. PubMed ID: 8313434
[TBL] [Abstract][Full Text] [Related]
32. An alpha 2-macroglobulin receptor-dependent mechanism for the plasma clearance of transforming growth factor-beta 1 in mice.
LaMarre J; Hayes MA; Wollenberg GK; Hussaini I; Hall SW; Gonias SL
J Clin Invest; 1991 Jan; 87(1):39-44. PubMed ID: 1702100
[TBL] [Abstract][Full Text] [Related]
33. Binding of transforming growth factor-beta 1 to immobilized human alpha 2-macroglobulin.
Webb DJ; Crookston KP; Hall SW; Gonias SL
Arch Biochem Biophys; 1992 Feb; 292(2):487-92. PubMed ID: 1370602
[TBL] [Abstract][Full Text] [Related]
34. Fatty acids modulate transforming growth factor-beta activity and plasma clearance.
Ling TY; Huang YH; Lai MC; Huang SS; Huang JS
FASEB J; 2003 Aug; 17(11):1559-61. PubMed ID: 12824279
[TBL] [Abstract][Full Text] [Related]
35. Counteracting effects of dexamethasone and alpha 2-macroglobulin on inhibition of proliferation of normal and neoplastic rat hepatocytes by transforming growth factors-beta type 1 and type 2.
Wollenberg GK; LaMarre J; Semple E; Farber E; Gauldie J; Hayes MA
Int J Cancer; 1991 Jan; 47(2):311-6. PubMed ID: 1703130
[TBL] [Abstract][Full Text] [Related]
36. Pericyte growth and contractile phenotype: modulation by endothelial-synthesized matrix and comparison with aortic smooth muscle.
Newcomb PM; Herman IM
J Cell Physiol; 1993 May; 155(2):385-93. PubMed ID: 8482730
[TBL] [Abstract][Full Text] [Related]
37. Proteoglycans and vascular cell proliferation.
Wight TN; Potter-Perigo S; Aulinskas T
Am Rev Respir Dis; 1989 Oct; 140(4):1132-5. PubMed ID: 2508521
[TBL] [Abstract][Full Text] [Related]
38. Fucans, sulfated polysaccharides extracted from brown seaweeds, inhibit vascular smooth muscle cell proliferation. I. Comparison with heparin for antiproliferative activity, binding and internalization.
Logeart D; Prigent-Richard S; Jozefonvicz J; Letourneur D
Eur J Cell Biol; 1997 Dec; 74(4):376-84. PubMed ID: 9438134
[TBL] [Abstract][Full Text] [Related]
39. Characterization of rat aortic smooth muscle cells resistant to the antiproliferative activity of heparin following long-term heparin treatment.
Bârzu T; Herbert JM; Desmoulière A; Carayon P; Pascal M
J Cell Physiol; 1994 Aug; 160(2):239-48. PubMed ID: 8040184
[TBL] [Abstract][Full Text] [Related]
40. Effects of transforming growth factor-beta 1 on human arterial smooth muscle cells in vitro.
Björkerud S
Arterioscler Thromb; 1991; 11(4):892-902. PubMed ID: 2065041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
